600557.SHG Jiangsu Kanion Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
12.83 CNY
Close of Nov 4, 2026
10.69 16.61
Market cap
CNY 7.26B
P/E
22.9x
P/B
1.44x
ROE
5.7%
Dividend yield
1.27%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600557.SHG undervalued?

Graham number
Price12.83
Graham value10.59
Premium21.2%

600557.SHG trades 21.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Kanion Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Jiangsu Kanion Pharmaceutical Co Ltd yet.

Jiangsu Kanion Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Kanion Pharmaceutical Co Ltd

Jiangsu Kanion Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals. The company offers Chinese medicine for anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. It also provides herb extracts and formula granules, well as OEM/ODM services. The company was founded in 1975 and is based in Lianyungang, China.

Full company profile